Oligonucleotide-Based Therapies for Renal Diseases

The global burden of chronic kidney disease (CKD) is increasing every year and represents a great cost for public healthcare systems, as the majority of these diseases are progressive. Therefore, there is an urgent need to develop new therapies. Oligonucleotide-based drugs are emerging as novel and...

Descripción completa

Detalles Bibliográficos
Autores principales: Cartón-García, Fernando, Saande, Cassondra Jeanette, Meraviglia-Crivelli, Daniel, Aldabe, Rafael, Pastor, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001091/
https://www.ncbi.nlm.nih.gov/pubmed/33809425
http://dx.doi.org/10.3390/biomedicines9030303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001091/
https://www.ncbi.nlm.nih.gov/pubmed/33809425
http://dx.doi.org/10.3390/biomedicines9030303

Ejemplares similares